Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 8/20 | 0.79 |
| ▸ | SRD5A2 | P31213 | 6/20 | 0.79 |
| ▸ | AR | P10275 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8823379 | 1.00 | SRD5A1 (0.79) | SRD5A1SRD5A2AR | |
| SCHEMBL8823396 | 0.90 | SRD5A1 (0.76) | SRD5A1SRD5A2AR | |
| SCHEMBL8823398 | 0.90 | SRD5A1 (0.76) | SRD5A1SRD5A2AR | |
| SCHEMBL7757861 | 0.90 | SRD5A1 (0.84) | SRD5A1SRD5A2AR | |
| SCHEMBL7755911 | 0.90 | SRD5A1 (0.84) | SRD5A1SRD5A2AR | |
| SCHEMBL7756370 | 0.89 | SRD5A1 (0.82) | SRD5A1SRD5A2AR | |
| SCHEMBL7756373 | 0.89 | SRD5A1 (0.82) | SRD5A1SRD5A2AR | |
| SCHEMBL8894610 | 0.89 | SRD5A1 (1.00) | SRD5A1SRD5A2AR | |
| SCHEMBL8894599 | 0.89 | SRD5A1 (1.00) | SRD5A1SRD5A2AR | |
| SCHEMBL7754606 | 0.88 | SRD5A1 (0.84) | SRD5A1SRD5A2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0538192-B1 | New 17-beta-substituted aza-androstanderivatives | CIBA GEIGY AG (CH) | 1997-04-23 | — | — | EP | disclosed |
| US-5304562-A | Inhibitors of 5-alpha-reductase; treating prostate disorders | CIBA-GEIGY CORPORATION (US) | 1994-04-19 | — | — | US | disclosed |
| EP-0538192-A1 | New 17-beta-substituted aza-androstanderivatives | CIBA-GEIGY AG (CH) | 1993-04-21 | — | — | EP | disclosed |